Țară: Statele Unite ale Americii
Limbă: engleză
Sursă: NLM (National Library of Medicine)
ZINC SULFATE HEPTAHYDRATE (UNII: N57JI2K7WP) (ZINC CATION - UNII:13S1S8SF37), CUPRIC SULFATE (UNII: LRX7AJ16DT) (CUPRIC CATION - UNII:8CBV67279L), MANGANESE SULFATE (UNII: W00LYS4T26) (MANGANESE CATION (2+) - UNII:H6EP7W5457), CHROMIC CHLORIDE (UNII: KB1PCR9DMW) (CHROMIC CATION - UNII:X1N4508KF1)
American Regent, Inc.
ZINC SULFATE HEPTAHYDRATE
ZINC CATION 22 mg in 1 mL
INTRAVENOUS
PRESCRIPTION DRUG
This formulation is indicated for use as a supplement to intravenous solutions given for TPN. Administration of the solution in TPN solutions helps to maintain plasma levels of zinc, copper, manganese, and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. MULTITRACE ® - 4 CONCENTRATE should not be given undiluted by direct injection into a peripheral vein because of the potential of infusion phlebitis.
MULTITRACE ® - 4 CONCENTRATE (TRACE ELEMENTS INJECTION 4, USP) Each mL provides: Zinc 5 mg, Copper 1 mg, Manganese 0.5 mg, and Chromium 10 mcg. NDC 0517-7201-25 1 mL Single Dose Vial Packaged in boxes of 25 NDC 0517-7210-25 10 mL Multiple Dose Vial* Packaged in boxes of 25 *Contains 0.9% Benzyl Alcohol as an antimicrobial preservative. AMERICAN REGENT, INC. SHIRLEY, NY 11967 IN7201 Rev. 8/18
unapproved drug other
MULTITRACE -4- TRACE ELEMENTS 4 INJECTION, SOLUTION, CONCENTRATE AMERICAN REGENT, INC. _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- MULTITRACE - 4 CONCENTRATE (TRACE ELEMENTS INJECTION 4, USP) FOR IV USE AFTER DILUTION RX ONLY DESCRIPTION MULTITRACE® - 4 CONCENTRATE (TRACE ELEMENTS INJECTION 4, USP) is a sterile nonpyrogenic solution containing four Trace Elements for use as an additive for Total Parenteral Nutrition (TPN). Each mL provides: Zinc 5 mg, Copper 1 mg, Manganese 0.5 mg and Chromium 10 mcg. Each mL contains: Zinc Sulfate Heptahydrate 22 mg (equivalent to 5 mg Zinc); Cupric Sulfate Pentahydrate 3.93 mg (equivalent to 1 mg Copper); Manganese Sulfate Monohydrate 1.54 mg (equivalent to 0.5 mg Manganese); Chromic Chloride Hexahydrate 51.3 mcg (equivalent to 10 mcg Chromium); and Water for Injection, q.s. pH of the solution may have been adjusted with Sulfuric Acid and/or Sodium Hydroxide. The 10 mL Multiple Dose Vial contains 0.9% Benzyl Alcohol as an antimicrobial preservative. CLINICAL PHARMACOLOGY ZINC has been identified as a cofactor for over 70 different enzymes, including alkaline phosphatase, lactic dehydrogenase and both RNA and DNA polymerase. Zinc facilitates wound healing, helps maintain normal growth rates, normal skin hydration and senses of taste and smell. Providing zinc during TPN prevents development of the following deficiency symptoms: parakeratosis, hypogeusia, anorexia, dysosmia, geophagia, hypogonadism, growth retardation and hepatosplenomegaly. At plasma levels below 20 mcg zinc/100 mL, dermatitis followed by alopecia has been reported for TPN patients. COPPER is essential as a cofactor for serum ceruloplasmin, an oxidase necessary for proper formation of the iron carrier protein, transferrin. Copper also helps maintain normal rates of red and white blood cell formation. Scorbutic type bone changes seen in infants fed exclusively wi Citiți documentul complet